ORIC Pharmaceuticals Inc (ORIC) stock has fallen -76.03% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ORIC stock a score of 33 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 1. ORIC's rank also includes a short-term technical score of 4. The fundamental score for ORIC is 94. In addition to the average rating from Wall Street analysts, ORIC stock has a mean target price of $19.00. This means analysts expect the stock to rise 302.54% over the next 12 months.
ORIC has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ORIC!
ORIC Pharmaceuticals Inc (ORIC) stock is higher by 1.84% while the S&P 500 has risen 1.13% as of 10:14 AM on Tuesday, Apr 12. ORIC has risen $0.09 from the previous closing price of $4.63 on volume of 111,518 shares. Over the past year the S&P 500 is higher by 8.10% while ORIC has fallen -76.03%. ORIC lost -$2.07 per share in the over the last 12 months.
Click Here to get the full Stock Report for ORIC Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
